IP Library Granted Patent US 12,625,065
Granted Patent B2
US 12,625,065 · App. 17/968,674 · Granted May 12, 2026

Systems and methods for multianalyte detection

Inventors: Dena C. Marrinucci (San Diego, CA); Randal L. Erman (San Marcos, CA); Bala S. Manian (San Diego, CA)
Assignee: Truvian Sciences, Inc.
G01N21/253B01L3/5085B01L3/545G01N21/6452G01N21/6454G01N21/6456G01N33/5304B01L2200/028B01L2300/0681B01L2300/0803B01L2300/0829G01N2021/1738G01N2021/6471
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,625,065
App. No.
17/968,674
Granted
May 12, 2026
Kind
B2
Abstract

Provided herein are systems, devices and methods for performing multianalyte detection in a biological sample, such as a human blood sample. Multiwell plates useful for performing multianalyte detection are also provided. The systems, devices and methods provided herein relate to the field of direct-to-consumer diagnostics (DTC diagnostics) and are useful, e.g., for facilitating consumer access to consumer healthcare and consumer wellness information. Other uses of the systems, devices and methods provided herein relate to the fields of medical research and drug discovery.

Claims (18)

1 . A method of performing point-of-care assays for a plurality of analytes in a liquid sample, the method being performed within a single diagnostic system, the method comprising:

A. providing

a multiwell plate comprising a plurality of wells, each well containing a portion of the liquid sample, the multiwell plate having a translucent bottom and opaque well walls wherein:

i) a first well contains a first reagent comprising a fluorogenic substrate or a fluorescently labeled binding protein configured to emit a fluorescent signal upon interaction with a first analyte in the sample; and

ii) a second well contains a second reagent comprising a chromogenic substrate configured to produce a detectable absorbance change upon interaction with a second analyte in the sample;

a single light source;

a single CMOS;

a motor;

a platform configured to receive the multiwell plate, the platform comprises platform magnets, platform vertical keys and an opaque film

wherein the opaque film is disposed on an upper surface of the platform;

wherein a peripheral portion of the multiwell plate comprising a plurality of overhang wells including the first well and the second well, overhangs the platform and a selected overhang well from the plurality of overhang wells is within an optical path of the light source and CMOS and is aligned to permit transmission of light through the translucent bottom of the first overhang well without obstruction from the platform or the motor;

the platform vertical keys engaged with a seat by a seat vertical key and platform magnets engaged with the seat by seat magnets in the seat, the seat coupled to the motor; and

a processor operatively connected to the CMOS;

B. moving, under control of the motor, the multiwell plate relative to the single CMOS and single light source, such that the first well of the plurality of overhang wells is aligned with the CMOS and the light source;

C. directing light from the single light source to the translucent bottom of the first well of the plurality of overhang wells and detecting by the CMOS a fluorescence emission generated upon interaction between a first analyte in the sample and the first reagent;

D. moving, under control of the motor, the multiwell plate relative to the single CMOS and single light source, such that the second well of the plurality of overhang wells is aligned with the CMOS and the light source;

E. directing light from the single light source to the translucent bottom of the second well of the plurality of overhang wells and detecting by the CMOS transmitted or absorbed light generated upon interaction between a second analyte in the sample and the second reagent;

F. processing, by the processor, (i) the detected fluorescence emission from the CMOS to generate analyte measurements for the first analyte in the liquid sample and (ii) the transmitted or absorbed light detected from the CMOS to generate analyte measurements for the second analyte in the liquid sample.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2022
From: MARRINUCCI, DENA C.; ERMAN, RANDAL L.; MANIAN, BALA S.
To: TRUVIAN SCIENCES, INC.
Reel/Frame 061461/0123 →
Continuity (3)
Continuation 16082878
Provisional Application 62312191 · Mar 23, 2016
Related Publication 20230228674A1 · Jul 20, 2023
References Cited (100)
US 4042462A · Johnson et al. · 1977 [cited by applicant]
US 4042463A · Haque et al. · 1977 [cited by applicant]
US 4656009A · Benajam · 1987 [cited by applicant]
US 4911642A · Knowles · 1990 [cited by applicant]
US 5693233A · Schembri · 1997 [cited by applicant]
US 6143248A · Kellogg et al. · 2000 [cited by applicant]
US 6235531B1 · Kopf-Sill et al. · 2001 [cited by applicant]
US 6302134B1 · Kellogg et al. · 2001 [cited by applicant]
US 6399361B2 · Brotherston et al. · 2002 [cited by applicant]
US 6548788B2 · Kellogg et al. · 2003 [cited by applicant]
US 6582662B1 · Kellogg et al. · 2003 [cited by applicant]
US 6632399B1 · Kellogg et al. · 2003 [cited by applicant]
US 6752961B2 · Kopf-Sill et al. · 2004 [cited by applicant]
US 6811755B2 · McLuen et al. · 2004 [cited by applicant]
US 6818435B2 · Carvalho et al. · 2004 [cited by applicant]
US 7094354B2 · Pugia et al. · 2006 [cited by applicant]
US 7238538B2 · Freitag et al. · 2007 [cited by applicant]
US 7790110B2 · Cho et al. · 2010 [cited by applicant]
US 7881262B2 · Shousterman · 2011 [cited by applicant]
US 7947186B2 · Soares et al. · 2011 [cited by applicant]
US 7998411B2 · Kopf-Sill et al. · 2011 [cited by applicant]
US 8119393B2 · Qinwei · 2012 [cited by applicant]
US 8221701B2 · Cho et al. · 2012 [cited by applicant]
US D672050S · Lee et al. · 2012 [cited by applicant]
US 8372357B2 · Andersson et al. · 2013 [cited by applicant]
US 8731721B2 · Heiner et al. · 2014 [cited by applicant]
US 8932538B2 · Kim et al. · 2015 [cited by applicant]
US 8945914B1 · Schaff et al. · 2015 [cited by applicant]
US 8962346B2 · Schaff et al. · 2015 [cited by applicant]
US 8969070B2 · Yoo · 2015 [cited by applicant]
US 9108198B2 · Kim et al. · 2015 [cited by applicant]
US 9164091B2 · Kim · 2015 [cited by applicant]
US 9186668B1 · Schaff et al. · 2015 [cited by applicant]
US 9186672B2 · Amasia et al. · 2015 [cited by applicant]
US 9213040B2 · Hwang et al. · 2015 [cited by applicant]
US 9244065B1 · Schaff et al. · 2016 [cited by applicant]
US 9279818B2 · Yoo · 2016 [cited by applicant]
US 9304129B2 · Schaff et al. · 2016 [cited by applicant]
US 9410127B2 · Kim et al. · 2016 [cited by applicant]
US 9421541B2 · Moon et al. · 2016 [cited by applicant]
US 9500579B1 · Sommer et al. · 2016 [cited by applicant]
US 9616424B2 · Lee et al. · 2017 [cited by applicant]
US 9624474B2 · Park · 2017 [cited by applicant]
US 9625916B2 · Garcia Da Fonseca et al. · 2017 [cited by applicant]
US 9726685B2 · Lee et al. · 2017 [cited by applicant]
US 9737889B2 · Moon et al. · 2017 [cited by applicant]
US 9816987B2 · Mehra et al. · 2017 [cited by applicant]
US 9829426B2 · Lee et al. · 2017 [cited by applicant]
US 20020031833A1 · Heyneker et al. · 2002 [cited by applicant]
US 20030127609A1 · El-Hage et al. · 2003 [cited by applicant]
US 20030161761A1 · Williams et al. · 2003 [cited by applicant]
US 20050048575A1 · Coassin et al. · 2005 [cited by applicant]
US 20050123445A1 · Blecka et al. · 2005 [cited by applicant]
US 20050136545A1 · Schmid et al. · 2005 [cited by applicant]
US 20060160210A1 · Mori et al. · 2006 [cited by applicant]
US 20100055766A1 · Hwang et al. · 2010 [cited by applicant]
US 20110086778A1 · Herrmann et al. · 2011 [cited by applicant]
US 20110151435A1 · Mehra et al. · 2011 [cited by applicant]
US 20110189701A1 · Kim · 2011 [cited by applicant]
US 20110269151A1 · Kim · 2011 [cited by applicant]
US 20120028850A1 · Lee · 2012 [cited by examiner]
US 20120053068A1 · Remacle · 2012 [cited by examiner]
US 20120142089A1 · Park · 2012 [cited by applicant]
US 20120300194A1 · Zimenkov · 2012 [cited by examiner]
US 20130203634A1 · Jovanovich et al. · 2013 [cited by applicant]
US 20130280748A1 · Gebetsroither · 2013 [cited by examiner]
US 20140017806A1 · Lee · 2014 [cited by applicant]
US 20140045168A1 · Childs · 2014 [cited by examiner]
US 20140287524A1 · Lee et al. · 2014 [cited by applicant]
US 20140341788A1 · Kim et al. · 2014 [cited by applicant]
US 20150064774A1 · Moon et al. · 2015 [cited by applicant]
US 20150090674A1 · Lee et al. · 2015 [cited by applicant]
US 20150226652A1 · Jayavanth et al. · 2015 [cited by applicant]
US 20150321192A1 · Lee · 2015 [cited by applicant]
US 20150360225A1 · Schaff et al. · 2015 [cited by applicant]
US 20160038939A1 · Min et al. · 2016 [cited by applicant]
US 20160252499A1 · Wang · 2016 [cited by examiner]
US 20170108438A1 · Zimenkov · 2017 [cited by examiner]
US 20170108494A1 · Mehra et al. · 2017 [cited by applicant]
US 20170151559A1 · Da Fonseca et al. · 2017 [cited by applicant]
US 20170176306A1 · Boehm et al. · 2017 [cited by applicant]
US 20170304826A1 · Lee et al. · 2017 [cited by applicant]
US 20170354970A1 · Reis et al. · 2017 [cited by applicant]
US 20180038853A1 · Mehra et al. · 2018 [cited by applicant]
US 20220244249A1 · Korpimäki · 2022 [cited by examiner]
WO WO9533986A1 · 1995 [cited by applicant]
WO WO2009093838A9 · 2010 [cited by applicant]
WO WO2011084697A2 · 2011 [cited by applicant]
WO WO2011093602A2 · 2011 [cited by applicant]
WO WO2011160015A2 · 2011 [cited by applicant]
WO WO2014010927A1 · 2014 [cited by applicant]
WO WO2016204638A2 · 2016 [cited by applicant]
WO WO2016204638A3 · 2017 [cited by applicant]
WO WO2017103029A1 · 2017 [cited by applicant]
WO WO2017212031A1 · 2017 [cited by applicant]
WO WO2018005464A1 · 2018 [cited by applicant]
US 7,833,478 B2, 11/2010, Andersson et al. (withdrawn) [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/US2017/023784, mailed Oct. 4, 2018, 9 Pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2017/023784, mailed Jul. 27, 2017, 12 Pages. [cited by applicant]
Theranos' Elizabeth Holmes Speaks at AACC Meeting. “Theranos Science & Technology: The Miniaturization of Laboratory Testing,” American Association for Clinical Chemistry [Video] [Screen captures from video retrieved on… [cited by applicant]